Access Official Technical PDF

Share Summary:LinkedInEmail

For industrial business leaders, an initial public offering document can offer a formal record of a company’s financing plans, corporate history and proposed market listing. The Mahickra Chemicals IPO red herring prospectus, dated April 2, 2018, sets out those details for the company’s proposed public issue. It is a historical securities filing, not a technical or operational profile: the information presented here describes the offer and its stated terms, rather than establishing the company’s manufacturing capabilities or performance.

Mahickra Chemicals IPO: the proposed offer

The prospectus described an initial public offering comprising a fresh issue of up to 2,100,000 equity shares, each with a face value of Rs. 10. The issue price and aggregate proceeds were not yet filled in in the red herring prospectus. The final price was to be determined through the book-building process, in consultation with the book running lead manager.

Of the proposed shares, up to 108,000 were reserved for the market maker. The remaining portion—up to 1,992,000 shares—was identified as the net issue. The prospectus said the offer and net issue would represent specified percentages of post-issue paid-up equity capital, but those percentages were also left blank in this version.

The bid period was scheduled to open on April 16, 2018, and close on April 18, 2018. The price band and minimum bid lot were to be decided and announced before the opening date. Because the price and some issue particulars remained subject to finalization, the document should be read as a red herring prospectus, not as a complete statement of final offer terms.

Company history and proposed listing

According to the filing, the business began as a partnership firm called Mahak Dye Chem Industries, constituted by a partnership deed dated June 21, 1994. Following a partners’ special resolution in September 2017, it was converted into a public limited company. Mahickra Chemicals Limited received its fresh certificate of incorporation on November 13, 2017.

The company proposed to list its equity shares on NSE Emerge, the SME platform of the National Stock Exchange of India. The prospectus reported that NSE had issued an in-principle approval letter on March 19, 2018 for the proposed listing. In-principle approval is part of the stated listing process; it is not, by itself, confirmation that trading had started or that a market for the shares would be active.

For industrial decision-makers assessing a supplier, partner or potential investment, this distinction matters. A prospectus can provide corporate and offer information, but the sections reproduced here do not detail plant capacity, production processes, product specifications, automation systems or operating results. Those matters should not be inferred from the company name or from the fact that it proposed an IPO.

How the ASBA application process worked

The filing stated that prospective investors were required to apply through the Application Supported by Blocked Amount (ASBA) process. Under the process described, an applicant submitted bank-account details and authorized a Self-Certified Syndicate Bank to block the application amount. The amount was not treated as freely available to the applicant while blocked; the prospectus described its transfer to the public issue account on the designated date.

The document also outlined the roles of the intermediaries involved, including the book running lead manager, registrar, banks and designated application channels. It named Pantomath Capital Advisors Private Limited as lead manager and Bigshare Services Private Limited as registrar. These roles support the administration of an issue; they do not constitute a recommendation to invest.

Risks highlighted in the prospectus

The prospectus emphasized that this was the company’s first public issue and that no formal market for its equity shares had existed before listing. It cautioned that the issue price should not be treated as an indication of the post-listing market price, and that no assurance could be given about sustained trading or the price at which shares might trade.

It also included a general warning that equity investments involve risk and that investors should assess the company, the issue and the risk factors themselves. The filing explicitly stated that the securities had not been recommended or approved by the Securities and Exchange Board of India, and that SEBI did not guarantee the accuracy or adequacy of the prospectus.

What industrial readers should take away

The Mahickra Chemicals IPO filing is useful as a snapshot of a proposed 2018 SME public issue: it records the company’s stated conversion from partnership to public limited company, the planned share offer, the intended NSE Emerge listing and the application framework. It also makes clear that key pricing details were still to be finalized and that trading outcomes were uncertain.

For technical and operational diligence, however, the prospectus information summarized here is not enough to assess production capability, quality systems or automation maturity. Keep the document’s scope in view: it is an offer disclosure, not an engineering audit or supplier qualification report. Any assessment should distinguish verified operational evidence from corporate and securities disclosures, and should account for the risks the prospectus itself identifies.

Access Official Technical PDF

About The Author